Ficlatuzumab (Anti-HGF / SF)
Ficlatuzumab (Anti-HGF / SF) is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). It inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion and can be used to treat head and neck squamous cell carcinoma (HNSCC). MW :150 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2661 |
Sku # | A2661-1mg*5 |
Pricing | 1mg*5, $970.00 |